We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBRX icon
176
Moleculin Biotech
MBRX
$2.34M
$549K 0.01%
6,240
+300
+5% +$34.6K
HEPA
177
DELISTED
Hepion Pharmaceuticals
HEPA
$526K 0.01%
10,320
+2,520
+32% +$186K
NCEL
178
NewcelX Ltd
NCEL
$19.4M
$501K 0.01%
5,778
+348
+6% +$21.1K
ONON icon
179
On Holding
ONON
$12.6B
$497K 0.01%
12,811
-146,898
-92% -$5.37M
WATT icon
180
Energous
WATT
$86.6M
$445K 0.01%
13,600
+4,214
+45% +$183K
GROY.WS icon
181
Gold Royalty Corp Warrants
GROY.WS
$145M
$418K 0.01%
+2,200,000
New +$392K
RPM icon
182
RPM International
RPM
$13.9B
$417K 0.01%
3,872
+588
+18% +$65.1K
ELTX icon
183
Elicio Therapeutics
ELTX
$74.6M
$411K 0.01%
+100,000
New +$846K
GNPX icon
184
Genprex
GNPX
$2.59M
$411K 0.01%
198
+109
+122% +$293K
SJM icon
185
J.M. Smucker
SJM
$12.6B
$368K ﹤0.01%
+3,377
New +$382K
MO icon
186
Altria Group
MO
$114B
$367K ﹤0.01%
+8,051
New +$357K
ALP
187
Alpha Compute
ALP
$4.54M
$319K ﹤0.01%
75,089
-8,205
-10% -$49.9K
CPRI icon
188
Capri Holdings
CPRI
$1.88B
$319K ﹤0.01%
9,629
+3,507
+57% +$127K
BEATW icon
189
Heartbeam Inc Warrant
BEATW
$315K ﹤0.01%
500,000
– –
TFFP
190
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$308K ﹤0.01%
+185,695
New +$487K
BRK.B icon
191
Berkshire Hathaway Class B
BRK.B
$1.11T
$304K ﹤0.01%
747
-547
-42% -$224K
GXAI
192
Gaxos.ai
GXAI
$8.85M
$286K ﹤0.01%
103,000
-5,000
-5% -$22.3K
VTAK icon
193
Catheter Precision
VTAK
$914K
$279K ﹤0.01%
2,513
-758
-23% -$77.1K
APCXW
194
DELISTED
AppTech Payments Corp Warrant
APCXW
$270K ﹤0.01%
715,000
– –
ATXI
195
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$263K ﹤0.01%
+75,000
New +$436K
SONN
196
DELISTED
Sonnet BioTherapeutics
SONN
$255K ﹤0.01%
+34,000
New +$459K
GOVX icon
197
GeoVax Labs
GOVX
$3.75M
$255K ﹤0.01%
3,200
-3,920
-55% -$172K
ARMK icon
198
Aramark
ARMK
$15B
$247K ﹤0.01%
+7,254
New +$235K
OLOX
199
Olenox Industries
OLOX
$7.02M
$244K ﹤0.01%
133
+19
+17% +$43.7K
NXGLW icon
200
NexGel Inc Warrant
NXGLW
$240K ﹤0.01%
550,000
– –
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.